External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology Lung Cancer

Lung Cancer

Lung cancer is the most common cancer in the world but still remains a challenge both in the clinical and research settings.

From studying the biology of lung cancer cells in the lab to leading clinical trials testing cutting-edge treatments, Roche is committed to addressing the medical need for therapies that extend patients’ lives.

What's new
Treatment management
Upcoming congresses
Access to Roche and Genentech’s latest medical information
View related congresses

Disease Education

The role of the Blood-Brain Barrier in lung cancer treatment

Some types of cancer, such as anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), frequently spread into the brain and central nervous system. A key challenge of treating these brain metastases is the blood-brain barrier, which you can learn more about in this video.

Watch the video
Open asset
Share page

Unleashing the T-Cell army

Watch this video that describes the cancer immunity cycle and how a tumour interacts with the human immune system.

Watch the video
Open asset
Share page

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.